Neubase Therapeutics Stock Price, News & Analysis
NBSE
NASDAQ
Company Description
Welcome to the overview page for Neubase Therapeutics (NBSE), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Neubase Therapeutics.
Financial Highlights
$0
Revenue (TTM)
-$1,821,112
Net Income (TTM)
-$0.66
-$2,002,565
Operating Cash Flow
2.87
-$2,813,176
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Neubase Therapeutics (NBSE)?
The current stock price of Neubase Therapeutics (NBSE) is $0.378 as of February 7, 2025.
What is the market cap of Neubase Therapeutics (NBSE)?
The market cap of Neubase Therapeutics (NBSE) is approximately 1.4M. Learn more about what market capitalization means .
What is the revenue (TTM) of Neubase Therapeutics (NBSE) stock?
The trailing twelve months (TTM) revenue of Neubase Therapeutics (NBSE) is $0.
What is the net income of Neubase Therapeutics (NBSE)?
The trailing twelve months (TTM) net income of Neubase Therapeutics (NBSE) is -$1,821,112.
What is the earnings per share (EPS) of Neubase Therapeutics (NBSE)?
The diluted earnings per share (EPS) of Neubase Therapeutics (NBSE) is -$0.66 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Neubase Therapeutics (NBSE)?
The operating cash flow of Neubase Therapeutics (NBSE) is -$2,002,565. Learn about cash flow.
What is the current ratio of Neubase Therapeutics (NBSE)?
The current ratio of Neubase Therapeutics (NBSE) is 2.87, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Neubase Therapeutics (NBSE)?
The operating income of Neubase Therapeutics (NBSE) is -$2,813,176. Learn about operating income.